Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
0.94
0.04 (4.76%)
At close: Aug 15, 2025, 3:58 PM
0.95
1.58%
After-hours: Aug 15, 2025, 07:26 PM EDT
Chemomab Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.96M | -3.48M | -3.63M | -3.87M | -3.45M | -4.07M | -7.97M | -8.75M | -8.27M | -8.08M | -6.19M | -5.1M | -5.04M | -2.97M | -2.77M | -1.7M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 16.17K | 18.94K | 16K | 16K | 14K | 17K | 14K | 13K | 11K | 9K | 7K | 7K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | 238K | 130K | 639K | 484K | 740K | 836K | 761K | 874K | 1.01M | 441K | 527K | 43K |
Other Working Capital | n/a | n/a | n/a | n/a | -332.6K | 315.47K | -301K | 538K | 1.37M | 2.16M | -232K | 355K | 269K | -71K | -3.4M | 80K |
Other Non-Cash Items | 2.96M | 3.48M | 3.63M | 3.87M | 347.69K | 1.84M | 531.93K | -12.88K | -20.37M | 1.13M | 819.42K | 750.63K | 1.01M | 456.88K | 514.14K | -221.68K |
Deferred Income Tax | n/a | n/a | n/a | n/a | -256.43K | -1.64M | -531.93K | 12.88K | 20.37M | -1.13M | -819.42K | n/a | -1.01M | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | -556.44K | -1.28M | -171K | 1.07M | 1.81M | 1.97M | -286K | 506K | 1.12M | -62K | -3.37M | 361K |
Operating Cash Flow | n/a | n/a | n/a | n/a | -3.9M | -5.13M | -7.49M | -7.19M | -5.7M | -5.25M | -5.7M | -3.71M | -2.89M | -2.58M | -5.61M | -1.29M |
Capital Expenditures | n/a | n/a | n/a | n/a | -29.46 | 6.93 | -2K | -1K | -1K | -42K | -11K | -14K | -134K | -240.89 | -102K | -3K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.45M | -5M | -21.43M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 1.86M | 3.92M | -4.27M | 14.43M | 9.38M | 6.02M | 1.74M | 2.4M | n/a | n/a | n/a | 989.65 |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 1.72M | 3.99M | -4.27K | 14.43K | -32.54K | 92.26K | 1.74M | 2.4M | 4K | 2.29K | -20.5M | 1K |
Investing Cash Flow | n/a | n/a | n/a | n/a | 1.86M | 3.92M | -4.27M | 14.43M | 9.35M | 6.07M | 1.73M | 2.38M | -19.58M | -5M | -20.6M | -2K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.21M | n/a | n/a | n/a | n/a | -72K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 2.14M | 3K | 1.37M | n/a | 82K | 39K | 22K | n/a | n/a | n/a | n/a | 2.43M |
Financial Cash Flow | n/a | n/a | n/a | n/a | 2.14M | 5.74K | 1.37M | -2.97K | -869K | 39K | 22K | 12.03K | -81K | -72K | 13.43M | 47.8M |
Net Cash Flow | n/a | n/a | n/a | n/a | 140.2K | -1.23M | -10.39M | 7.25M | 2.78M | 858K | -3.95M | -1.33M | -22.56M | -7.65M | -12.78M | 46.5M |
Free Cash Flow | n/a | n/a | n/a | n/a | -3.9M | -5.13M | -7.49M | -7.19M | -5.7M | -5.3M | -5.71M | -3.73M | -3.03M | -2.58M | -5.71M | -1.3M |